Purchases and Sales Made in Q3 2022 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q3 2022. The information is specifically focused on institutions that hold shares of Ascendis Pharma A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-38.4K- 59.13% |
$3.23M - $4.23M
|
26.5K
$4.32M
|
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-43.9K- 6.42% |
$3.69M - $4.84M
|
640K
$104M
|
|
|
Nov 14, 2022
Q3 2022
|
Spyglass Capital Management LLC
San Francisco, CA |
SELL
|
- |
-160K- 14.4% |
$13.4M - $17.6M
|
950K
$155M
|
|
|
Nov 10, 2022
Q3 2022
|
Artisan Partners Limited Partnership
Milwaukee, WI |
SELL
|
- |
-324K- 4.33% |
$27.2M - $35.7M
|
7.15M
$1.16B
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-458K- 13.8% |
$38.5M - $50.5M
|
2.86M
$465M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-458K- 13.8% |
$38.5M - $50.5M
|
2.86M
$465M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.29M- 24.98% |
$108M - $142M
|
3.87M
$631M
|